Category Archives: Drug Development

The Passionate Scientist Against Cancer, Clay Siegall

Career choices may be shaped by different factors or variables that one encounters in life. For instance, a professional footballer may have grown up in an area where the game was not only played but also treasured and cherished. A teacher could have come from a family background of teachers, and therefore choose to fulfill the lineage status. Hence, experiences and settings seem to have a lot to do with what one is today. It has not been different for Clay Siegall.


Clay Siegall has dedicated his life to the service of patients. Growing up, he watched his father battle with cancer to his ultimate demise. It dawned on him that if more tools were available for the oncologists’ use, there would have been a better chance that his father’s life would have been prolonged. As a result, a desire surged in him to improve these tools. He proceeded to George Washington University where he earned a Doctorate in Genetics and spent the next year working for Bristol-Myers Squibb Pharmaceutical Research Institute. Here, he acquired not only significant industrial experience but also management skills that would later be of help when running his company.


Clay Siegall is the Co-founder, President, CEO, and Chairman of the Board of Seattle Genetics. He is a scientist with a keen eye on cancer therapies. His dedication and commitment have seen the company to its current global position, where it is developing an antibody-drug conjugate (ADC) and that gained FDA the approval. Under his able direction, the company has secured multiple strategic licenses for its unique ADC technology. Moreover, he has remarkably raised its capital levels, having secured over 1.2 billion dollars through public and private financing.


Clay Siegall has also worked with the National Cancer Institute and also the National Institute of Health. Presently, he serves on the Boards of Washington Roundtable, Ultragenyx Pharmaceutical, and Alder BioPharmaceutical. His tremendous work has earned him recognition and numerous awards like the 2012 Pacific Northwest Ernst &Young Entrepreneur of the Year, among others. Besides, he has authored over 70 publications, and he is a holder of 15 patents. He insists that alliances with other industry leaders and innovators extend the reach of any business towards fulfilling its set goals and objectives.